What is chloroquine phosphate injection used for?
Pharmaceutical Product Monograph: Chloroquine Phosphate Injection (40 mg/mL)
In the pharmaceutical industry, Chloroquine Phosphate is a 4-aminoquinoline derivative. As a pharmacist and manufacturer, I view this molecule as a “Rapid-Acting Blood Schizonticide”—it is technically designed to eliminate the asexual erythrocytic forms of Plasmodium parasites.
At your WHO-GMP facility in Mumbai, Chloroquine 40 mg/mL (often in 5 mL or 30 mL vials) is a specialized SKU. While oral tablets are the standard for mild malaria, the injection is a critical care intervention used when the patient cannot tolerate oral medication due to persistent vomiting or severe clinical distress.
Therapeutic Profile: Primary Indications
Chloroquine Phosphate injection is primarily indicated for the treatment of acute malarial attacks.
| Indication | Clinical Context | Technical Rationale |
| Acute Malaria | P. vivax, P. ovale, P. malariae | Gold Standard: Highly effective against these species, though resistance in P. falciparum has limited its use for that strain globally. |
| Severe Vomiting | Inability to swallow | Used to achieve rapid therapeutic blood levels when oral tablets would be lost to emesis. |
| Extraintestinal Amebiasis | Hepatic Amebic Abscess | Chloroquine concentrates heavily in the liver (up to 200x blood levels), making it effective against Entamoeba histolytica in liver tissue. |
| Autoimmune (Off-label IV) | Systemic Lupus (SLE) | Occasionally used in specialized hospital settings for acute flares of SLE or Rheumatoid Arthritis when oral hydroxychloroquine is not an option. |
Mechanism: Heme Polymerization Inhibition
Chloroquine acts as a “molecular poison” within the parasite’s digestive system:
Accumulation: The drug enters the parasite’s acidic food vacuole.
Heme Buildup: The parasite normally digests human hemoglobin, releasing toxic Heme. To survive, the parasite crystallizes this Heme into non-toxic Hemozoin.
Crystallization Blockade: Chloroquine technically binds to the Heme, preventing its crystallization.
Lysis: The buildup of free, toxic Heme destroys the parasite’s membranes, leading to rapid cell death.
The Pharmacist’s “Technical Warning”
The “Cardiotoxicity” Alert: As a pharmacist, I must emphasize that Chloroquine has a narrow therapeutic index. Rapid IV injection can cause sudden Cardiovascular Collapse or fatal arrhythmias.
The IM Safety Rule: For safety, Chloroquine is technically preferred as a Slow Intramuscular (IM) injection. If IV must be used, it must be diluted and infused very slowly over several hours.
Retinopathy Risk: While more common with long-term oral use, high cumulative doses can lead to permanent retinal damage (“Bull’s Eye Maculopathy”).
Pediatric Sensitivity: Children are extremely sensitive to Chloroquine. Dosing must be strictly calculated by weight ($5 \text{ mg/kg}$ of base) to avoid fatal toxicity.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
The “Base vs. Salt” USP: On your digital marketplace, clarify the 40 mg/mL concentration. Usually, this refers to Chloroquine Phosphate, which is equivalent to 25 mg of Chloroquine Base. Clear labeling of “Base Equivalent” is a technical requirement for international B2B tenders.
The “Liver-Targeted” Marketing: For your B2B dossiers in regions with high amebiasis rates (like parts of SE Asia and Africa), market this as a secondary treatment for Hepatic Abscesses where standard metronidazole therapy has failed.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Chloroquine Phosphate 40 mg/mL to support your firm’s registration in international B2B tenders for tropical medicine.